Literature DB >> 925569

Measurement of free and occupied cytoplasmic and nuclear androgen receptor sites in rat ventral prostate gland.

P Davies, P Thomas, K Griffiths.   

Abstract

A method has been developed which allows the estimation of occupied and unoccupied androgen receptor sites in both cytoplasmic and nuclear fractions of rat ventral prostate. The procedure involves precipitation of receptor proteins and incubation of precipitates with labelled 5alpha-dihydrotestosterone. Uptake of 3H-labelled steroid at 0--4 degrees C gives an indication of free receptor, whereas binding at a raised temperature (15 degrees C) allows estimation of occupied receptor. Non-specific binding was measured in the presence of a 100-fold excess of unlabelled 5alpha-dilhydrotestosterone. The exchange method was specific for androgens, and specific binding was detected only in fractions of androgen-dependent tissues. The method can be applied to cytosol, whole nuclei, chromatin and salt-extractable and salt-resistant protein preparations from nuclear fractions, and gives a reliable estimate of total receptor sites when occupied as compared with control measurements of unoccupied sites.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925569     DOI: 10.1677/joe.0.0740393

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  3 in total

1.  Human hepatocellular carcinoma tumor xenografts. Their androgen-receptor status and growth responses to castration.

Authors:  A A Dunk; N Kyprianou; P Davies; H C Thomas
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

2.  The uptake of radioiodinated 5 alpha-dihydrotestosterone by the prostate of intact and castrated rats.

Authors:  M Tarle; R Padovan; S Spaventi
Journal:  Eur J Nucl Med       Date:  1981-02

3.  Androgenic regulation of elongation of polyribonucleotide chains on rat ventral-prostate chromatin.

Authors:  P Thomas; P Davies; K Griffiths
Journal:  Biochem J       Date:  1978-02-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.